Background Immunotherapy with clodronate-encapsulated liposomes, which induce
macrophage depletion, has been studied extensively. However, previously reported …

Monocytes/macrophages are phagocytic innate immune cells playing a pivotal role in tissue
homeostasis, inflammation, and antitumor immunity in a microenvironment‐dependent …

Here we report a new and efficient approach of macrophage specific drug delivery by
coating liposomes with albumin. Activated albumin was reacted with liposomes containing …

Background: Tumor-associated macrophages (TAMs) are critical in tumor progression and
metastasis. Selective targeting of TAMs holds great potential to ameliorate the …

In the treatment of solid tumors, the complex barriers composed of cancer‐associated
fibroblasts (CAFs) prevent drug delivery and T cells infiltration into tumor tissues. Although …

Nanomedicine holds immense potential for therapeutic manipulation of phagocytic immune
cells. However, in vitro studies often fail to accurately translate to the complex in vivo …

A liposome mediated macrophage “suicide” approach has been developed, based on the
liposome mediated internalization of the small hydrophilic molecule clodronate in …

Nanoparticles are widely used as carrier materials for biomedical applications such as
functional and morphological imaging diagnosis and therapeutic drug delivery. Based on …

Stimulation of monocytes with immunomodulating agents can harness the immune system to
treat a long range of diseases, including cancers, infections and autoimmune diseases. To …

Liposomes are the most widely used nanocarrier platform for the delivery of therapeutic and
diagnostic agents, and a number of liposomes have been approved for use in clinical …